Why Did Piper Sandler Give Intra-Cellular Therapies Inc (ITCI) Stock Overweight Rating?
Intra-Cellular Therapies Inc (ITCI) stock saw a modest uptick, ending the day at $126.5 which represents a slight increase of $0.30 or 0.24% from the prior close of $126.2. The stock opened at $126.64 and touched a low of $126.
That's changed: Lyons is acknowledged heir apparent at a giant fintech where he'll become CEO by July at the latest.
In a report released today, Arvind Ramnani from Piper Sandler maintained a Hold rating on PayPal Holdings (PYPL – Research Report), with a ...
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 14.59% ...
Tesla remains the “top buy-and-hold” stock for analysts at Piper Sandler, who massively raised their price target for the ...
Piper Sandler raised the firm’s price target on PayPal (PYPL) to $93 from $88 and keeps a Neutral rating on the shares. The firm believes that ...
Piper Sandler Companies operates as an investment bank and institutional securities firm that serves corporations, private equity groups, public entities, non-profit entities, and institutional ...
MarketWatch on MSN3d
Tesla’s ‘Trump bump’ fades as stock falls alongside rest of EV sectorTesla shares TSLA ended the day down 0.6%, after falling as much as 4% intraday, tracking losses in the broader EV space, ...
NEW YORK, January 13, 2025--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a managing director to the healthcare investment ...
Salesforce shows potential for growth with dominant market share and AI-driven interest from Agentforce, according to Piper ...
Piper Sandler reiterated an Overweight rating and $670 price target on Meta Platforms (META) after CEO Mark Zuckerberg said in a Facebook post ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback